申请人:Merck Patent Gesellschaft mit beschrankter Haftung
公开号:US04251538A1
公开(公告)日:1981-02-17
Indolealkylamines of the formula ##STR1## wherein Ind is 1-R.sup.4 -2-R.sup.5 -indol-3-yl or the corresponding group in which the benzene ring is monosubstituted to trisubstituted by alkyl, O-alkyl, S-alkyl, OH, F, Cl, Br, CF.sub.3 or CN; A is --(CH.sub.2).sub.4 --, --(CH.sub.2).sub.3 --CO-- or --CO--(CH.sub.2).sub.2 --CO--; R.sup.1 is H or methyl; R.sup.2 is H or together with R.sup.3 is a C--C bond; R.sup.3 is H or together with R.sup.2 is a C--C bond; R.sup.4 and R.sup.5 are each H, alkyl, or phenyl; and Ar is phenyl or phenyl monosubstituted or disubstituted by alkyl, F, Cl, Br, I or CF.sub.3 ; wherein alkyl in each case is of 1-4 carbon atoms; and the physiologically acceptable acid addition salts thereof possess valuable pharmacological properties.
Indolealkylamines的公式为##STR1##其中Ind是1-R.sup.4-2-R.sup.5-吲哚-3-基或相应的基团,苯环经烷基、O-烷基、S-烷基、OH、F、Cl、Br、CF.sub.3或CN单取代至三取代;A是--(CH.sub.2).sub.4--,--(CH.sub.2).sub.3--CO--或--CO--(CH.sub.2).sub.2--CO--;R.sup.1是H或甲基;R.sup.2是H或与R.sup.3一起是C-C键;R.sup.3是H或与R.sup.2一起是C-C键;R.sup.4和R.sup.5各自是H,烷基或苯基;Ar是苯基或经烷基、F、Cl、Br、I或CF.sub.3单取代或双取代;其中每种情况下的烷基为1-4个碳原子;及其生理上可接受的酸盐具有有价值的药理特性。